1|Page
NR 509 WEEK 8 ADVANCED HEALTH
ASSESSMENT FINAL ACTUAL EXAM
PREP 2026 ALL QUESTIONS AND
CORRECT DETAILED ANSWERS WITH
RATIONALES ALREADY A GRADED WITH
EXPERT FEEDBACK |NEW AND REVISED
A 42-year-old female website developer presents for an annual
preventive examination with questions about breast cancer
screening. She is concerned about the radiation exposure
associated with mammography and is interested in magnetic
resonance imaging (MRI) as a possible alternative for routine
screening. She is otherwise healthy with no family history of
breast, ovarian, or colon cancer. Which of the following is true
about MRI as a screening modality for breast cancer in the
general population? - ANSWER- Sensitivity of screening for
breast cancer increases with breast MRI at the expense of
specificity.
Sensitivity of screening for breast cancer increases with
breast MRI at the expense of specificity. Increased
sensitivity (in this case, higher-resolution imaging to pick up
subtler disease) is often traded for reduced specificity (in the
form of discovering many small items of no pathological
significance). This is a core concept in designing screening
tests—very sensitive tests often pick up false positives, while
very specific tests often rule out disease effectively by
,2|Page
missing many actual cases. Balance must be sought between
these two when setting thresholds for positive and negative
screens. Breast cancer screening by MRI has been well
studied in the general population is incorrect. This screening
modality has only been studied in high-risk populations.
This patient is an ideal candidate for screening via breast
MRI based on current evidence is incorrect. This patient
meets no known criteria for screening with breast MRI
(known BRCA mutation, history of chest radiation, etc.).
Women at low lifetime risk of breast cancer (<20%) are
recommended to undergo screening MRI is incorrect. Only
women at high lifetime risk (>20%) are current
recommended to utilize breast MRI as a screening tool.
Known BRCA1 or BRCA2 mutation is insufficient criteria
to justify screening with breast MRI is incorrect. The
BRCA1 or BRCA2 mutation confers a risk >20% of breast
cancer over a lifetime, which is considered sufficient criteria
for screening with MRI rather than mammogram.
A 35-year-old G0P0 woman presents to clinic with a complaint
of bilateral nipple discharge. This discharge started several
weeks ago and has occurred at irregular intervals since that time.
She does not complain of local tenderness, redness, fever, or any
other systemic symptoms aside from slightly irregular periods
over the last few months. On examination, she is able to express
a small amount of discharge, which is sent to the laboratory and
found to be consistent with breast milk but without any signs of
,3|Page
blood or pus. Screening laboratories are also sent, which reveal a
normal blood count, metabolic panel, thyroid-stimulating
hormone, and human chorionic gonadotropin (HCG) level.
Further laboratories are still pending. Which of the following is
the most likely diagnosis? - ANSWER- Prolactinoma
Rationale: Prolactinomas are pituitary tumors that secrete
prolactin, which causes the production of breast milk and
can suppress menstruation. Mastitis is incorrect. Mastitis is
a breast infection that is typically painful and characterized
by a focal area of redness and tenderness in one breast.
Ductal carcinoma in situ is incorrect. While nipple discharge
should raise suspicion for breast cancer, in this case the
discharge is neither bloody nor purulent, and it is notably
bilateral. A prudent provider may still order a mammogram
and/or ultrasound, but the answer is unlikely to be breast
cancer. Paget disease of the breast is incorrect. This
condition may present with nipple discharge, but it is usually
bloody. Occult pregnancy is incorrect. This patient has a
negative HCG test, which is the standard hormonal
laboratory examination used to determine pregnancy in both
urine and serum tests.
A 22-year-old G0P0 undergraduate student presents to clinic
after finding a breast mass on breast self-examination (BSE) at
home. The mass is nontender without skin changes, erythema, or
overlying swelling. She has heard that most breast cancers are
, 4|Page
found by patients themselves, and she is very concerned that she
may have breast cancer. Which of the following is true about
BSE and self-detection of breast cancer? - ANSWER- a. Most
masses that women find at home and bring to a provider's
attention turn out to be malignant.
Rationale: This patient is more likely to find a fibroadenoma
than a cancer on self-examination. In this patient's age range
(15-25 years), palpable masses are most likely to be benign
fibroadenomas. Most masses that women find at home and
bring to a provider's attention turn out to be malignant is
incorrect. About 11% of complaints of breast masses turn
out to be malignant, leaving the vast majority (89%)
noncancerous. The most likely breast mass this patient is
likely to find in herself is an abscess complicating underlying
mastitis is incorrect. This patient has neither the symptoms
of mastitis (localized swelling/erythema/tenderness with
generalized fever) nor the risk factors for this condition
(pregnancy and/or breastfeeding), making mastitis a very
unlikely diagnosis. Because of this patient's age, breast
masses should not be pursued with imaging and diagnosis
because the risk of cancer is so low is incorrect. Though the
risk of cancer in this patient is low, the consequence of
missing a cancer diagnosis is quite high; for that reason,
definitive diagnosis should be pursued for almost all breast
masses. Because of this patient's age, breast masses should
not be pursued with imaging and diagnosis because the risk
of cancer is so low is incorrect. BSE suffers from notoriously
NR 509 WEEK 8 ADVANCED HEALTH
ASSESSMENT FINAL ACTUAL EXAM
PREP 2026 ALL QUESTIONS AND
CORRECT DETAILED ANSWERS WITH
RATIONALES ALREADY A GRADED WITH
EXPERT FEEDBACK |NEW AND REVISED
A 42-year-old female website developer presents for an annual
preventive examination with questions about breast cancer
screening. She is concerned about the radiation exposure
associated with mammography and is interested in magnetic
resonance imaging (MRI) as a possible alternative for routine
screening. She is otherwise healthy with no family history of
breast, ovarian, or colon cancer. Which of the following is true
about MRI as a screening modality for breast cancer in the
general population? - ANSWER- Sensitivity of screening for
breast cancer increases with breast MRI at the expense of
specificity.
Sensitivity of screening for breast cancer increases with
breast MRI at the expense of specificity. Increased
sensitivity (in this case, higher-resolution imaging to pick up
subtler disease) is often traded for reduced specificity (in the
form of discovering many small items of no pathological
significance). This is a core concept in designing screening
tests—very sensitive tests often pick up false positives, while
very specific tests often rule out disease effectively by
,2|Page
missing many actual cases. Balance must be sought between
these two when setting thresholds for positive and negative
screens. Breast cancer screening by MRI has been well
studied in the general population is incorrect. This screening
modality has only been studied in high-risk populations.
This patient is an ideal candidate for screening via breast
MRI based on current evidence is incorrect. This patient
meets no known criteria for screening with breast MRI
(known BRCA mutation, history of chest radiation, etc.).
Women at low lifetime risk of breast cancer (<20%) are
recommended to undergo screening MRI is incorrect. Only
women at high lifetime risk (>20%) are current
recommended to utilize breast MRI as a screening tool.
Known BRCA1 or BRCA2 mutation is insufficient criteria
to justify screening with breast MRI is incorrect. The
BRCA1 or BRCA2 mutation confers a risk >20% of breast
cancer over a lifetime, which is considered sufficient criteria
for screening with MRI rather than mammogram.
A 35-year-old G0P0 woman presents to clinic with a complaint
of bilateral nipple discharge. This discharge started several
weeks ago and has occurred at irregular intervals since that time.
She does not complain of local tenderness, redness, fever, or any
other systemic symptoms aside from slightly irregular periods
over the last few months. On examination, she is able to express
a small amount of discharge, which is sent to the laboratory and
found to be consistent with breast milk but without any signs of
,3|Page
blood or pus. Screening laboratories are also sent, which reveal a
normal blood count, metabolic panel, thyroid-stimulating
hormone, and human chorionic gonadotropin (HCG) level.
Further laboratories are still pending. Which of the following is
the most likely diagnosis? - ANSWER- Prolactinoma
Rationale: Prolactinomas are pituitary tumors that secrete
prolactin, which causes the production of breast milk and
can suppress menstruation. Mastitis is incorrect. Mastitis is
a breast infection that is typically painful and characterized
by a focal area of redness and tenderness in one breast.
Ductal carcinoma in situ is incorrect. While nipple discharge
should raise suspicion for breast cancer, in this case the
discharge is neither bloody nor purulent, and it is notably
bilateral. A prudent provider may still order a mammogram
and/or ultrasound, but the answer is unlikely to be breast
cancer. Paget disease of the breast is incorrect. This
condition may present with nipple discharge, but it is usually
bloody. Occult pregnancy is incorrect. This patient has a
negative HCG test, which is the standard hormonal
laboratory examination used to determine pregnancy in both
urine and serum tests.
A 22-year-old G0P0 undergraduate student presents to clinic
after finding a breast mass on breast self-examination (BSE) at
home. The mass is nontender without skin changes, erythema, or
overlying swelling. She has heard that most breast cancers are
, 4|Page
found by patients themselves, and she is very concerned that she
may have breast cancer. Which of the following is true about
BSE and self-detection of breast cancer? - ANSWER- a. Most
masses that women find at home and bring to a provider's
attention turn out to be malignant.
Rationale: This patient is more likely to find a fibroadenoma
than a cancer on self-examination. In this patient's age range
(15-25 years), palpable masses are most likely to be benign
fibroadenomas. Most masses that women find at home and
bring to a provider's attention turn out to be malignant is
incorrect. About 11% of complaints of breast masses turn
out to be malignant, leaving the vast majority (89%)
noncancerous. The most likely breast mass this patient is
likely to find in herself is an abscess complicating underlying
mastitis is incorrect. This patient has neither the symptoms
of mastitis (localized swelling/erythema/tenderness with
generalized fever) nor the risk factors for this condition
(pregnancy and/or breastfeeding), making mastitis a very
unlikely diagnosis. Because of this patient's age, breast
masses should not be pursued with imaging and diagnosis
because the risk of cancer is so low is incorrect. Though the
risk of cancer in this patient is low, the consequence of
missing a cancer diagnosis is quite high; for that reason,
definitive diagnosis should be pursued for almost all breast
masses. Because of this patient's age, breast masses should
not be pursued with imaging and diagnosis because the risk
of cancer is so low is incorrect. BSE suffers from notoriously
